Coherus Biosciences (CHRS) PT Raised to $22 at Maxim Group
Tweet Send to a Friend
Maxim Group raised its price target on Coherus Biosciences (NASDAQ: CHRS) to $22.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
